0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editorial | ONLINE FIRST

Expression of Concern: Kiel et al. Efficacy of a hip protector to prevent hip fracture in nursing home residents: the HIP PRO randomized controlled trial. JAMA. 2007;298(4):413-422. FREE

Howard Bauchner, MD; Phil B. Fontanarosa, MD, MBA
[+] Author Affiliations

Author Affiliations: Dr Bauchner is Editor in Chief and Dr Fontanarosa is Executive Deputy Editor, JAMA.


JAMA. 2012;308(23):2519. doi:10.1001/jama.2012.14079.
Text Size: A A A
Published online

We hereby issue an Expression of Concern regarding the conduct of the research reported in the article entitled “Efficacy of a Hip Protector to Prevent Hip Fracture in Nursing Home Residents: The HIP PRO Randomized Controlled Trial,” published in the July 25, 2007, issue of JAMA.1 This study has been the subject of an investigation conducted by the Office for Human Research Protections (OHRP) in the Department of Health and Human Services regarding 45 CFR part 46, federal regulations that govern the ethical conduct of research.

After review of the reports from OHRP dated June 23, 2011,2 February 17, 2012,3 and July 5, 2012,4 and evaluation of additional information requested by JAMA and provided to us by the participating institutions (Hebrew SeniorLife [an affiliate of Harvard Medical School], Washington University School of Medicine, and the University of Maryland School of Medicine), we concur with the OHRP determination that the failure to notify research participants about potential risks they may have experienced by participating in the study represents serious concerns regarding their protection as research participants in this study. Therefore, we are issuing this Expression of Concern regarding the ethical conduct of this study. When the study was first published in 2007, the authors acknowledged1 and an editorial in JAMA5 anticipated that having only 1 hip protected could have altered the gait of participants and the propensity to fall to the protected side. However, at that time, the authors were not forthcoming with providing information JAMA requested that would have been informative in understanding this risk.2(p9)

As a corrective action, OHRP required the investigators to notify the study participants or their legally authorized representatives of its findings in writing.3 To inform our readers and other researchers about the seriousness and consequences of these matters, we requested that the institutions consent to our posting of a template of these notices as Supplemental material on the JAMA website and encouraged them to consider a similar posting on their institutional websites.

Based on information reported to JAMA by Hebrew SeniorLife, Washington University School of Medicine, and the University of Maryland School of Medicine in response to our requests, there was no evidence provided that raised concerns about the scientific integrity of the data and the veracity of the study conclusions; therefore, we are taking no further action at this time. If additional information should become available about the ethical conduct of this study, about harms to patients that occurred by virtue of failure of notification of possible risk, or about the scientific integrity of the research, we will evaluate that information carefully and determine whether additional notifications will be necessary.

ARTICLE INFORMATION

Published Online: October 4, 2012. doi:10.1001/jama.2012.14079

Online-Only Material: The supplement containing the 3 institutional notices is available here.

Editorials represent the opinions of the authors and JAMA and not those of the American Medical Association.

Kiel DP, Magaziner J, Zimmerman S,  et al.  Efficacy of a hip protector to prevent hip fracture in nursing home residents: the HIP PRO randomized controlled trial.  JAMA. 2007;298(4):413-422
PubMed   |  Link to Article
 OHRP letter of June 23, 2011, in re: Human Research Protections Under Federalwide Assurances FWA-00000885, FWA-00002284 and FWA-00007145. http://www.hhs.gov/ohrp/detrm_letrs/YR11/jun11a.pdf. Accessed October 1, 2012
 OHRP letter of February 17, 2012, in re: Human Research Protections under Federalwide Assurances FWA-00000885, FWA-00002284 and FWA-00007145. http://www.hhs.gov/ohrp/detrm_letrs/YR12/feb12a.pdf. Accessed October 1, 2012
 OHRP letter of July 5, 2012, in re: Human Research Protections under Federalwide Assurances FWA-00000885. http://www.hhs.gov/ohrp/detrm_letrs/YR12/jul12b.pdf. Accessed October 1, 2012
Kannus P, Parkkari J. Hip protectors for preventing hip fracture.  JAMA. 2007;298(4):454-455
PubMed   |  Link to Article

Figures

Tables

References

Kiel DP, Magaziner J, Zimmerman S,  et al.  Efficacy of a hip protector to prevent hip fracture in nursing home residents: the HIP PRO randomized controlled trial.  JAMA. 2007;298(4):413-422
PubMed   |  Link to Article
 OHRP letter of June 23, 2011, in re: Human Research Protections Under Federalwide Assurances FWA-00000885, FWA-00002284 and FWA-00007145. http://www.hhs.gov/ohrp/detrm_letrs/YR11/jun11a.pdf. Accessed October 1, 2012
 OHRP letter of February 17, 2012, in re: Human Research Protections under Federalwide Assurances FWA-00000885, FWA-00002284 and FWA-00007145. http://www.hhs.gov/ohrp/detrm_letrs/YR12/feb12a.pdf. Accessed October 1, 2012
 OHRP letter of July 5, 2012, in re: Human Research Protections under Federalwide Assurances FWA-00000885. http://www.hhs.gov/ohrp/detrm_letrs/YR12/jul12b.pdf. Accessed October 1, 2012
Kannus P, Parkkari J. Hip protectors for preventing hip fracture.  JAMA. 2007;298(4):454-455
PubMed   |  Link to Article
CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Supplemental Content

Bauchner H, Fontanarosa PB. Expression of Concern: Kiel et al. Efficacy of a hip protector to prevent hip fracture in nursing home residents: the HIP PRO randomized controlled trial. JAMA. 2007;298(4):413-422. JAMA. doi: 10.1001/jama.2012.14079

Letters

Hebrew SeniorLife

Washington University in St Louis

University of Maryland

Supplemental Content

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 2

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
JAMAevidence.com

The Rational Clinical Examination
Clinical Scenario